Other Health

Pelago Announces Launch of Contingency Management Program

Retrieved on: 
Tuesday, April 9, 2024
Mental Health, Health, Technology, Health Technology, Other Health, General Health, Reward, ROI, Motivation, SAMHSA, Suds, Tobacco, Systematic review, Glasner, Multimedia, Substance Abuse, Economics, Meta-analysis

Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, has introduced contingency management to reward behaviors most likely to improve member engagement, motivation and health outcomes.

Key Points: 
  • Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, has introduced contingency management to reward behaviors most likely to improve member engagement, motivation and health outcomes.
  • With the introduction of this evidence-based treatment program, Pelago becomes the first nationwide digital substance use management provider to offer contingency management (CM), which will be incorporated into its comprehensive substance use disorder (SUDs) treatment offerings.
  • An earlier meta-analysis found that contingency management resulted in successful treatment episodes 61% of the time compared to 39% for other modalities.
  • For more information on how our contingency management program could benefit your population, visit www.pelagohealth.com Or contact a member of our team .

InfoBionic Rebrands Company Name to ‘InfoBionic.Ai’, Reinforcing Focus on AI-Enabled ECG

Retrieved on: 
Tuesday, April 9, 2024
Technology, Medical Devices, Health Technology, Telemedicine, Virtual Medicine, Cardiology, Software, Other Health, General Health, Health, Artificial Intelligence, Intelligence, ARC, Machine learning, Mayo Clinic, FDA, Heart, ECG, AI, Medical device

InfoBionic has always been dedicated to remaining at the cutting edge of patient care.

Key Points: 
  • InfoBionic has always been dedicated to remaining at the cutting edge of patient care.
  • Since the organization’s inception in 2015, AI and machine learning have been an integral part of InfoBionic’s remote cardiac telemetry offering.
  • In reality, this name change is just formalizing what we have already become,” says Stuart Long, CEO of InfoBionic.Ai.
  • “Our commitment to evolving remote cardiac telemetry monitoring through existing and novel AI-enabled ECG remains steadfast and unwavering.

Manatt Welcomes Leading Developmental Disability Leader to National Health Care Industry Group

Retrieved on: 
Tuesday, April 9, 2024
Public Policy, Government, Legal, General Health, Health, Consulting, Healthcare Reform, Professional Services, Other Health, Community, Face, Case management, Health equity, DHS, LLP, Private sector, Human, Manatt, Phelps & Phillips, Lawyer, Disability, Interim, Consultant, Nursing

Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the arrival of Senior Advisor Anna Lansky to the Firm’s Health Care industry group.

Key Points: 
  • Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the arrival of Senior Advisor Anna Lansky to the Firm’s Health Care industry group.
  • Most recently serving as the Interim Director of the Oregon Department of Human Services’ (DHS) Office of Developmental Disabilities Services (ODDS), Lansky will work with the Firm’s health care and state clients to align, strengthen and support care coordination efforts for their respective communities.
  • “Anna is a highly respected leader and trailblazer within the health care policy, government and regulatory arenas, making her an ideal fit for our growing integrated legal and consulting platform, especially as we continue to focus on improving the health care quality, delivery and access, and advancing health equity,” said Manatt CEO and Managing Partner Donna L. Wilson .
  • “With over 20 years of experience, including senior roles in analyzing, building and running state intellectual and developmental disability (I/DD) agencies, Anna brings a robust understanding of the core issues our clients face,” said Manatt Health Leader Bill Bernstein .

Bayer’s Consumer Health Division Announces Changes to North America Leadership Team

Retrieved on: 
Tuesday, April 9, 2024
Other Communications, Other Health, Marketing, Communications, General Health, Other Natural Resources, Fitness & Nutrition, Agriculture, Natural Resources, Science, Vitamins, Supplements, Other Science, Health, Research, Medical Supplies, Growth, Philosophy, Business administration, BBDO, Diversity, University, Equity, Walmart, Bayer, Love, P&G, Aspirin, BBA, CMO, Tenneco, Multimedia, Loratadine, Advance Auto Parts, Avivi

Today, Bayer announced Samantha Avivi as the new Chief Marketing Officer (CMO) for its Consumer Health division in North America.

Key Points: 
  • Today, Bayer announced Samantha Avivi as the new Chief Marketing Officer (CMO) for its Consumer Health division in North America.
  • She will report directly to Dave Tomasi, President, Consumer Health, North America for Bayer.
  • View the full release here: https://www.businesswire.com/news/home/20240409885941/en/
    “I’m pleased to welcome Samantha to Team Bayer to lead our North America marketing organization and join our efforts to achieve ‘Health for all, Hunger for none,‘” said Tomasi.
  • “I’m honored to take this leadership role with Bayer, a world leading company with a meaningful mission,” said Avivi.

Tetricus Labs Partners with Silver Hill Hospital on Research to Advance Precision Psychiatry

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Technology, Other Health, Health, Neurology, Mental Health, Research, Software, Artificial Intelligence, Hospitals, Science, Dow, Panic disorder, Psychiatry, Data science, Associate, Silver, Partnership, Patient, Tetricus, Bipolar disorder, Radiology, Neuroscience, Doctor of Philosophy, DSM-IV codes, Evercore, MD, Psychology, Silver Hill Hospital, Social anxiety disorder, Machine learning, Medical director, Yale University, Medicine, Nursing

Precision psychiatry startup Tetricus Labs has partnered with Silver Hill Hospital , one of the nation’s premier psychiatric hospitals, on a two-year feasibility study to assess how machine learning can significantly improve patient outcomes.

Key Points: 
  • Precision psychiatry startup Tetricus Labs has partnered with Silver Hill Hospital , one of the nation’s premier psychiatric hospitals, on a two-year feasibility study to assess how machine learning can significantly improve patient outcomes.
  • “We're patient-founded, patient-owned, and patient-run,” said Dow, CEO for Tetricus Labs.
  • Andrew J. Gerber, MD, PhD, President and Medical Director of Silver Hill Hospital, will join Tetricus Labs as a Medical Advisor to ensure Tetricus’ machine learning software is designed to fit within the busy workflow of hospital clinicians and staff, maximizing its accessibility for providers and potential impact on patient outcomes.
  • “This partnership represents our continued commitment to exploring innovative methods that can enhance our understanding of psychiatric disorders and improve patient outcomes."

Emet Surgical Accepted into Innosphere Ventures Life Sciences Incubator Program

Retrieved on: 
Tuesday, April 9, 2024
Oncology, Medical Devices, Health, Surgery, Other Health, General Health, U.S. FDA, ROI, Entrepreneurship, Cancer, Surgeon, Ecosystem, Pathology, Orientation

Emet Surgical , developers of innovative tools to improve surgery outcomes, today announced its acceptance into the Innosphere Ventures Life Sciences Incubator for pioneering startups, a program of impact nonprofit Innosphere Ventures .

Key Points: 
  • Emet Surgical , developers of innovative tools to improve surgery outcomes, today announced its acceptance into the Innosphere Ventures Life Sciences Incubator for pioneering startups, a program of impact nonprofit Innosphere Ventures .
  • Innosphere’s incubation programs support the commercialization efforts of entrepreneurs, technical founders and university researchers who are launching and scaling high-tech startups.
  • The Innosphere Ventures Regional Life Sciences Incubator accelerates the success of founders building technology and science-based companies through its incubation programs, office and specialized wet laboratory facilities, and venture capital funds.
  • "Emet Surgical’s innovative approach to improving surgery outcomes, born out of firsthand experience and a commitment to addressing critical challenges in the field, exemplifies the spirit of entrepreneurship and innovation that defines our cohort,” said Kevin Noble, Life Sciences Program Director for Innosphere.

OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Technology, Other Health, Health, General Health, Pharmaceutical, Health Technology, Research, Artificial Intelligence, Surgery, Science, University Challenge 2013–14, Partnership, Physician, Inflammation, Patient, American Academy, Standard of care, CRS, AI, Medtronic, PROPEL, ENT, Sinusitis, ESS, Adhesion, Pharmaceutical industry

The study focused on healthcare resource use (HCRU) and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent endoscopic sinus surgery (ESS).

Key Points: 
  • The study focused on healthcare resource use (HCRU) and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent endoscopic sinus surgery (ESS).
  • The study found that PROPEL devices are associated with lower HCRU and revision surgery during a 24-month follow-up period after ESS.
  • Thus, the use of PROPEL devices may lead to payer savings from reduced healthcare resource utilization.
  • “The results of this study demonstrate a rare win-win-win within healthcare,” said Amy Van Sach, president of Medtronic ENT.

U.S. Congressman Josh Gottheimer Champions Rare Disease Research With Sponsorship of Legislative Bill - H.Res.1039 - Advocating for Increased Funding for Charcot-Marie-Tooth Disease (CMT)

Retrieved on: 
Tuesday, April 9, 2024
Dental, Public Policy, Government, Healthcare Reform, Philanthropy, Biotechnology, Other Health, Health, General Health, Foundation, Stroke, Brain, NJ-5, Gene, Charcot–Marie–Tooth disease, Disease, Sympathetic nervous system, DSM-IV codes, Research, Hope, Quality of life, Hunting, Tax, Child, Spinal cord, Rare Disease Caucus, Legislation, Disability, ID, Bangladesh Technical Education Board, Hearing, CMT, Pharmaceutical industry

The resolution underscores the urgency of addressing the challenges of individuals diagnosed with Charcot-Marie-Tooth disease (CMT) and the need for robust research funding.

Key Points: 
  • The resolution underscores the urgency of addressing the challenges of individuals diagnosed with Charcot-Marie-Tooth disease (CMT) and the need for robust research funding.
  • “By collaborating with experts and advocates, we can give everyone struggling with Charcot-Marie-Tooth Disease hope.
  • Zaken's dedication reflects the grassroots efforts of young individuals committed to making a difference in the fight against rare diseases.
  • Regrettably, despite its profound impact, federal funding for CMT research witnessed a decrease in 2022 compared to 2021.

Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists

Retrieved on: 
Tuesday, April 9, 2024
Technology, Biotechnology, Health, Other Health, Pharmaceutical, Artificial Intelligence, Oncology, Practice Management, Software, Managed Care, General Health, Health Technology, Data Management, Clinical Trials, Cloud, Diagnosis, Google Cloud, Organization, Face, Medicine, Radiology, Drug discovery, Partnership, Ideation, Bias, BigQuery, Patient, Chronicle, Health care, Artificial intelligence, AI, Workload, Medical device

Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients.

Key Points: 
  • Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients.
  • As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud’s technology, including its generative AI (gen AI) tools.
  • The platform is built on Google Cloud and uses tools like Vertex AI, BigQuery, Healthcare API and Chronicle.
  • Bayer and Google Cloud are also working together to transform patient care worldwide through responsible AI adoption.

Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference

Retrieved on: 
Tuesday, April 9, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Other Health, Metro Toronto Convention Centre, Conference, Q&A

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre in Toronto from April 16-17, 2024.

Key Points: 
  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre in Toronto from April 16-17, 2024.
  • Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Tuesday, April 16, from 10:30 to 11:00 AM Eastern Time.
  • A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found here .